December 8, 2020 – Medtronic plc (Dublin, Ireland) announced the U.S. commercial launch of the Carpediem Cardio-Renal Pediatric Dialysis Emergency Machine. Following the U.S. Food and Drug Administration’s (FDA) marketing authorization, granted earlier this year, the first Carpediem systems in the U.S. were successfully installed and are in use at Cincinnati Children’s Hospital Medical Center.
The first-of-its-kind Carpediem system is indicated for use in acute kidney injury or fluid overloaded patients requiring hemodialysis or hemofiltration therapy.
It is intended to provide continuous renal replacement therapy (CRRT) to patients weighing between 2.5 and 10 kilograms.
Pediatric patients requiring CRRT have historically been treated with systems designed and indicated for adults and not approved for pediatric use, which can create potential clinical complications for neonatal patients. The Carpediem system is intended to address many of the challenges associated with current machines because it is the first CRRT system designed specifically for patients weighing between 2.5 and 10 kilograms.